Note 3 - Merger with Old Cytocom - Purchase Price - Assets Acquired and Liabilities Assumed (Details) - USD ($)	Sep. 30, 2021	Jul. 27, 2021	Dec. 30, 2020
Goodwill	$ 76,972,668		$ 0
Cleveland BioLabs, Inc. [Member]
Cash and cash equivalents		$ 13,116,460
Other receivables		25,142
Other current assets		44,507
Fixed assets - net		4,954
Panacela (67.57% ownership)		178,388
Total Tangible Assets		13,369,451
Accounts payable		(426,570)
Accrued expenses		(41,755)
Total Liabilities		(468,325)
Net Tangible Assets/Liabilities		12,901,126
In-process R&D		0
Total Intangible Assets Acquired		0
Goodwill		64,338,810
Total Net Assets Acquired		$ 77,239,936